262 results on '"Williams NR"'
Search Results
102. The fallacy of large survival gains from lung metastasectomy in colorectal cancer.
- Author
-
Treasure T, Macbeth F, Farewell V, Williams NR, and Fallowfield L
- Subjects
- Case-Control Studies, Humans, Lung Neoplasms secondary, Lung Neoplasms surgery, Observational Studies as Topic standards, Progression-Free Survival, Colorectal Neoplasms mortality, Lung Neoplasms mortality, Metastasectomy mortality
- Published
- 2021
- Full Text
- View/download PDF
103. Evidence for the role of the dorsal ventral lateral posterior thalamic nucleus connectivity in deep brain stimulation for Gilles de la Tourette syndrome.
- Author
-
Kakusa B, Saluja S, Barbosa DAN, Cartmell S, Espil FM, Williams NR, McNab JA, and Halpern CH
- Subjects
- Humans, Lateral Thalamic Nuclei, Thalamus diagnostic imaging, Deep Brain Stimulation, Tics, Tourette Syndrome diagnostic imaging, Tourette Syndrome therapy
- Abstract
Gilles de la Tourette syndrome (GTS) can manifest as debilitating, medically-refractory tics for which deep brain stimulation (DBS) of the centromedian-parafascicular complex (CM) can provide effective treatment. However, patients have reported benefit with activation of contacts dorsal to the CM and likely in the ventro-lateral thalamus (VL). At our institution, a case of a robust and durable response in a GTS patient required stimulation in the CM and more dorsally. We explore the structural connectivity of thalamic subregions associated with GTS using diffusion MRI tractography. Diffusion weighted images from 40 healthy Human Connectome Project (HCP) subjects and our GTS patient were analyzed. The VL posterior nucleus (VLp) and the CM were used as seeds for whole-brain probabilistic tractography. Leads were localized via linear registration of pre-/post-operative imaging and cross-referenced with the DBS Intrinsic Template Atlas. Tractography revealed high streamline probability from the CM and VLp to the superior frontal gyrus, rostral middle frontal gyrus, brainstem, and ventral diencephalon. Given reported variable responses to DBS along the thalamus, we segmented the VLp based on its connectivity profile. Ventral and dorsal subdivisions emerged, with streamline probability patterns differing between the dorsal VLp and CM. The CM, the most reported DBS target for GTS, and the dorsal VLp have different but seemingly complimentary connectivity profiles as evidenced by our patient who, at 1-year post-operatively, had significant therapeutic benefit. Stimulation of both regions may better target reward and motor circuits, resulting in enhanced symptom control for GTS., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
104. Pulmonary Metastasectomy for Colorectal Cancer: Randomized Controlled Trial.
- Author
-
Williams NR, Treasure T, and Macbeth F
- Subjects
- Humans, Prospective Studies, Survival Rate, Colorectal Neoplasms diagnostic imaging, Colorectal Neoplasms surgery, Lung Neoplasms diagnostic imaging, Lung Neoplasms surgery, Metastasectomy, Radiofrequency Ablation
- Published
- 2021
- Full Text
- View/download PDF
105. Pulmonary metastasectomy in colorectal cancer: health utility scores by EQ-5D-3L in a randomized controlled trial show no benefit from lung metastasectomy.
- Author
-
Brew-Graves C, Farewell V, Monson K, Milošević M, Williams NR, Morris E, Macbeth F, Treasure T, and Fallowfield L
- Subjects
- Humans, Lung, Quality of Life, Surveys and Questionnaires, Colorectal Neoplasms surgery, Metastasectomy
- Abstract
Aim: The aim was to assess the health utility of lung metastasectomy in the treatment of patients with colorectal cancer (CRC) using the EQ-5D-3L questionnaire., Methods: Multidisciplinary CRC teams at 14 sites recruited patients to a two-arm randomized controlled trial-Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC). Remote randomization was used, stratified by site and with minimization for seven known confounders. Participants completed the EQ-5D-3L questionnaire together with other patient reported outcome measures at randomization and then again at 3, 6, 12 and 24 months. These were returned by post to the coordinating centre., Results: Between December 2010 and December 2016, 93 participants were randomized, 91 of whom returned questionnaires. Survival and patient reported quality of life have been published previously, revealing no significant differences between the trial arms. Described here are patient reported data from the five dimensions of the EQ-5D-3L and the visual analogue scale (VAS) health state. No significant difference was seen at any time point. The estimated difference between control and metastasectomy patients was -0.23 (95% CI -0.113, 0.066) for the composite 0 to 1 index scale based on the descriptive system and 0.123 (95% CI -7.24, 7.49) for the 0 to 100 VAS scale., Conclusions: Following lung metastasectomy for CRC, no benefit was demonstrated for health utility, which alongside a lack of a survival or quality of life benefit calls into question the widespread use of the procedure., (© 2020 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.)
- Published
- 2021
- Full Text
- View/download PDF
106. Brain-Responsive Neurostimulation for Loss of Control Eating: Early Feasibility Study.
- Author
-
Wu H, Adler S, Azagury DE, Bohon C, Safer DL, Barbosa DAN, Bhati MT, Williams NR, Dunn LB, Tass PA, Knutson BD, Yutsis M, Fraser A, Cunningham T, Richardson K, Skarpaas TL, Tcheng TK, Morrell MJ, Roberts LW, Malenka RC, Lock JD, and Halpern CH
- Subjects
- Feasibility Studies, Nucleus Accumbens, Randomized Controlled Trials as Topic, Humans, Brain, Deep Brain Stimulation, Obesity therapy
- Abstract
Background: Loss of control (LOC) is a pervasive feature of binge eating, which contributes significantly to the growing epidemic of obesity; approximately 80 million US adults are obese. Brain-responsive neurostimulation guided by the delta band was previously found to block binge-eating behavior in mice. Following novel preclinical work and a human case study demonstrating an association between the delta band and reward anticipation, the US Food and Drug Administration approved an Investigational Device Exemption for a first-in-human study., Objective: To assess feasibility, safety, and nonfutility of brain-responsive neurostimulation for LOC eating in treatment-refractory obesity., Methods: This is a single-site, early feasibility study with a randomized, single-blinded, staggered-onset design. Six subjects will undergo bilateral brain-responsive neurostimulation of the nucleus accumbens for LOC eating using the RNS® System (NeuroPace Inc). Eligible participants must have treatment-refractory obesity with body mass index ≥ 45 kg/m2. Electrophysiological signals of LOC will be characterized using real-time recording capabilities coupled with synchronized video monitoring. Effects on other eating disorder pathology, mood, neuropsychological profile, metabolic syndrome, and nutrition will also be assessed., Expected Outcomes: Safety/feasibility of brain-responsive neurostimulation of the nucleus accumbens will be examined. The primary success criterion is a decrease of ≥1 LOC eating episode/week based on a 28-d average in ≥50% of subjects after 6 mo of responsive neurostimulation., Discussion: This study is the first to use brain-responsive neurostimulation for obesity; this approach represents a paradigm shift for intractable mental health disorders., (Copyright © 2020 by the Congress of Neurological Surgeons.)
- Published
- 2020
- Full Text
- View/download PDF
107. Photogeologic Map of the Perseverance Rover Field Site in Jezero Crater Constructed by the Mars 2020 Science Team.
- Author
-
Stack KM, Williams NR, Calef F 3rd, Sun VZ, Williford KH, Farley KA, Eide S, Flannery D, Hughes C, Jacob SR, Kah LC, Meyen F, Molina A, Nataf CQ, Rice M, Russell P, Scheller E, Seeger CH, Abbey WJ, Adler JB, Amundsen H, Anderson RB, Angel SM, Arana G, Atkins J, Barrington M, Berger T, Borden R, Boring B, Brown A, Carrier BL, Conrad P, Dypvik H, Fagents SA, Gallegos ZE, Garczynski B, Golder K, Gomez F, Goreva Y, Gupta S, Hamran SE, Hicks T, Hinterman ED, Horgan BN, Hurowitz J, Johnson JR, Lasue J, Kronyak RE, Liu Y, Madariaga JM, Mangold N, McClean J, Miklusicak N, Nunes D, Rojas C, Runyon K, Schmitz N, Scudder N, Shaver E, SooHoo J, Spaulding R, Stanish E, Tamppari LK, Tice MM, Turenne N, Willis PA, and Yingst RA
- Abstract
The Mars 2020 Perseverance rover landing site is located within Jezero crater, a ∼ 50 km diameter impact crater interpreted to be a Noachian-aged lake basin inside the western edge of the Isidis impact structure. Jezero hosts remnants of a fluvial delta, inlet and outlet valleys, and infill deposits containing diverse carbonate, mafic, and hydrated minerals. Prior to the launch of the Mars 2020 mission, members of the Science Team collaborated to produce a photogeologic map of the Perseverance landing site in Jezero crater. Mapping was performed at a 1:5000 digital map scale using a 25 cm/pixel High Resolution Imaging Science Experiment (HiRISE) orthoimage mosaic base map and a 1 m/pixel HiRISE stereo digital terrain model. Mapped bedrock and surficial units were distinguished by differences in relative brightness, tone, topography, surface texture, and apparent roughness. Mapped bedrock units are generally consistent with those identified in previously published mapping efforts, but this study's map includes the distribution of surficial deposits and sub-units of the Jezero delta at a higher level of detail than previous studies. This study considers four possible unit correlations to explain the relative age relationships of major units within the map area. Unit correlations include previously published interpretations as well as those that consider more complex interfingering relationships and alternative relative age relationships. The photogeologic map presented here is the foundation for scientific hypothesis development and strategic planning for Perseverance's exploration of Jezero crater.
- Published
- 2020
- Full Text
- View/download PDF
108. Pulmonary metastasectomy in colorectal cancer: PulMiCC and future trials.
- Author
-
Williams NR, Macbeth F, and Treasure T
- Abstract
Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/qims-20-774). The authors have no conflicts of interest to declare.
- Published
- 2020
- Full Text
- View/download PDF
109. Pulmonary Metastasectomy in Colorectal Cancer: the PulMiCC randomised controlled trial.
- Author
-
Treasure T, Leonard P, Milosevic M, Williams NR, Macbeth F, and Farewell V
- Subjects
- Colorectal Neoplasms mortality, Follow-Up Studies, Humans, Lung Neoplasms mortality, Single-Blind Method, Survival Analysis, Treatment Outcome, Colorectal Neoplasms pathology, Lung Neoplasms secondary, Lung Neoplasms surgery, Metastasectomy methods, Pneumonectomy methods
- Published
- 2020
- Full Text
- View/download PDF
110. Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed.
- Author
-
Milosevic M, Edwards J, Tsang D, Dunning J, Shackcloth M, Batchelor T, Coonar A, Hasan J, Davidson B, Marchbank A, Grumett S, Williams NR, Macbeth F, Farewell V, and Treasure T
- Subjects
- Humans, Neoplasm Staging, Retrospective Studies, Survival Rate, Colorectal Neoplasms pathology, Colorectal Neoplasms surgery, Lung Neoplasms surgery, Metastasectomy
- Abstract
Aim: Lung metastases from colorectal cancer are resected in selected patients in the belief that this confers a significant survival advantage. It is generally assumed that the 5-year survival of these patients would be near zero without metastasectomy. We tested the clinical effectiveness of this practice in Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC), a randomized, controlled noninferiority trial., Method: Multidisciplinary teams in 14 hospitals recruited patients with resectable lung metastases into a two-arm trial. Randomization was remote and stratified according to site, with minimization for age, sex, primary cancer stage, interval since primary resection, prior liver involvement, number of metastases and carcinoembryonic antigen level. The trial management group was blind to patient allocation until after intention-to-treat analysis., Results: From 2010 to 2016, 93 participants were randomized. These patients were 35-86 years of age and had between one and six lung metastases at a median of 2.7 years after colorectal cancer resection; 29% had prior liver metastasectomy. The patient groups were well matched and the characteristics of these groups were similar to those of observational studies. The median survival after metastasectomy was 3.5 (95% CI: 3.1-6.6) years compared with 3.8 (95% CI: 3.1-4.6) years for controls. The estimated unadjusted hazard ratio for death within 5 years, comparing the metastasectomy group with the control group, was 0.93 (95% CI: 0.56-1.56). Use of chemotherapy or local ablation was infrequent and similar in each group., Conclusion: Patients in the control group (who did not undergo lung metastasectomy) have better survival than is assumed. Survival in the metastasectomy group is comparable with the many single-arm follow-up studies. The groups were well matched with features similar to those reported in case series., (© 2020 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.)
- Published
- 2020
- Full Text
- View/download PDF
111. Synchronized cervical VNS with accelerated theta burst TMS for treatment resistant depression.
- Author
-
George MS, Caulfield KA, O'Leary K, Badran BW, Short EB, Huffman SM, Li X, Kerns SE, and Williams NR
- Abstract
Competing Interests: Declaration of competing interest Dr. George is the principal investigator at MUSC which is an enrolling site in a LivaNova coordinated VNS depression trial (RECOVER).
- Published
- 2020
- Full Text
- View/download PDF
112. Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression.
- Author
-
Cole EJ, Stimpson KH, Bentzley BS, Gulser M, Cherian K, Tischler C, Nejad R, Pankow H, Choi E, Aaron H, Espil FM, Pannu J, Xiao X, Duvio D, Solvason HB, Hawkins J, Guerra A, Jo B, Raj KS, Phillips AL, Barmak F, Bishop JH, Coetzee JP, DeBattista C, Keller J, Schatzberg AF, Sudheimer KD, and Williams NR
- Subjects
- Adult, Clinical Protocols, Cognition, Female, Functional Neuroimaging methods, Humans, Magnetic Resonance Imaging methods, Male, Monitoring, Physiologic methods, Neuropsychological Tests, Psychiatric Status Rating Scales, Remission Induction methods, Depressive Disorder, Treatment-Resistant diagnosis, Depressive Disorder, Treatment-Resistant physiopathology, Depressive Disorder, Treatment-Resistant therapy, Gyrus Cinguli physiopathology, Prefrontal Cortex physiopathology, Transcranial Magnetic Stimulation methods
- Abstract
Objective: New antidepressant treatments are needed that are effective, rapid acting, safe, and tolerable. Intermittent theta-burst stimulation (iTBS) is a noninvasive brain stimulation treatment that has been approved by the U.S. Food and Drug Administration for treatment-resistant depression. Recent methodological advances suggest that the current iTBS protocol might be improved through 1) treating patients with multiple sessions per day at optimally spaced intervals, 2) applying a higher overall pulse dose of stimulation, and 3) precision targeting of the left dorsolateral prefrontal cortex (DLPFC) to subgenual anterior cingulate cortex (sgACC) circuit. The authors examined the feasibility, tolerability, and preliminary efficacy of Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), an accelerated, high-dose resting-state functional connectivity MRI (fcMRI)-guided iTBS protocol for treatment-resistant depression., Methods: Twenty-two participants with treatment-resistant depression received open-label SAINT. fcMRI was used to individually target the region of the left DLPFC most anticorrelated with sgACC in each participant. Fifty iTBS sessions (1,800 pulses per session, 50-minute intersession interval) were delivered as 10 daily sessions over 5 consecutive days at 90% resting motor threshold (adjusted for cortical depth). Neuropsychological testing was conducted before and after SAINT., Results: One participant withdrew, leaving a sample size of 21. Nineteen of 21 participants (90.5%) met remission criteria (defined as a score <11 on the Montgomery-Åsberg Depression Rating Scale). In the intent-to-treat analysis, 19 of 22 participants (86.4%) met remission criteria. Neuropsychological testing demonstrated no negative cognitive side effects., Conclusions: SAINT, an accelerated, high-dose, iTBS protocol with fcMRI-guided targeting, was well tolerated and safe. Double-blinded sham-controlled trials are needed to confirm the remission rate observed in this initial study.
- Published
- 2020
- Full Text
- View/download PDF
113. Education Level and Self-rated Health in the United States: Immigrants' Diminished Returns.
- Author
-
Assari S, Perez MU, Johnson N, Williams NR, Carrillo E, Garcia L, and Hollis XT
- Abstract
Introduction: Although education is among the major socioeconomic status (SES) resources that influence populations' and individuals' health, social marginalization may reduce the health gain that follows access to SES indicators such as education, a pattern called marginalization-related diminished return (MDR). The literature on MDRs, however, has been mainly derived from studies that have defined marginalization based on race, ethnicity, and sexual orientation. Thus, more research is needed on MDRs that may follow as a result of immigration. To extend what is known on immigration status related MDRs, this study compared a national sample of immigrants and non-immigrants for the effect of education on the poor self-rated health (SRH) of adults in the United States., Methods: With a cross-sectional design, this study employed data from the 2015 National Health Interview Survey (NHIS), a survey that had enrolled 33,654 adults who were either immigrants (n = 6225; 18.5%) or non-immigrants (n = 27 429; 81.5%). The independent variable was education level, treated as a categorical variable. The dependent variable was SRH treated as a dichotomous variable. Race, ethnicity, age, gender, marital status, and region were the confounders. Immigration (nativity) was the moderator. Logistic regression was used for data analysis., Results: Higher education credentials were associated with better SRH in the pooled sample; however, immigration showed a significant statistical interaction with education level (college graduation) on the outcome. This interaction was indicative of a smaller protective effect of college graduation on poor SRH among immigrants than non-immigrant adults., Conclusion: In line with the MDRs framework, the effect of education on SRH is weaker for immigrants than for non-immigrant adults. There is a need to help highly educated immigrants to mobilize their human capital to secure their best health outcomes, similar to non-immigrants. Such strategies may require bold and innovative policy solutions to reduce discrimination against immigrants, so they can more effectively translate their education and human capital into tangible outcomes such as health., Competing Interests: Conflict of Interest Disclosures The authors declare no conflicts of interest.
- Published
- 2020
- Full Text
- View/download PDF
114. Adjunctive repetitive transcranial magnetic stimulation delivers superior quality of life for focal epilepsy compared to anti-epileptic drugs: A meta-analytic utility prediction study.
- Author
-
Mahajan UV, Parker JJ, Williams NR, Bhati MT, Ku S, Grant G, Fisher RS, Stein SC, and Halpern CH
- Abstract
Competing Interests: Declaration of competing interest Casey Halpern MD has received consulting fees and speaking honoraria from Medtronic, NeuroPace and Boston Scientific. Robert Fisher MD is a consultant for and has received clinical trial support from Medtronic. None of the other authors have any conflict of interest to disclose.
- Published
- 2020
- Full Text
- View/download PDF
115. Transcranial Magnetic Stimulation Parameter Space: Wide Open for Exploration.
- Author
-
Bentzley BS and Williams NR
- Subjects
- Antidepressive Agents, Depression, Double-Blind Method, Humans, Depressive Disorder, Major, Transcranial Magnetic Stimulation
- Published
- 2020
- Full Text
- View/download PDF
116. Photodynamic Therapy in Primary Breast Cancer.
- Author
-
Banerjee SM, El-Sheikh S, Malhotra A, Mosse CA, Parker S, Williams NR, MacRobert AJ, Hamoudi R, Bown SG, and Keshtgar MR
- Abstract
Photodynamic therapy (PDT) is a technique for producing localized necrosis with light after prior administration of a photosensitizing agent. This study investigates the nature, safety, and efficacy of PDT for image-guided treatment of primary breast cancer. We performed a phase I/IIa dose escalation study in 12 female patients with a new diagnosis of invasive ductal breast cancer and scheduled to undergo mastectomy as a first treatment. The photosensitizer verteporfin (0.4 mg/kg) was administered intravenously followed by exposure to escalating light doses (20, 30, 40, 50 J; 3 patients per dose) delivered via a laser fiber positioned interstitially under ultrasound guidance. MRI (magnetic resonance imaging) scans were performed prior to and 4 days after PDT. Histological examination of the excised tissue was performed. PDT was well tolerated, with no adverse events. PDT effects were detected by MRI in 7 patients and histology in 8 patients, increasing in extent with the delivered light dose, with good correlation between the 2 modalities. Histologically, there were distinctive features of PDT necrosis, in contrast to spontaneous necrosis. Apoptosis was detected in adjacent normal tissue. Median follow-up of 50 months revealed no adverse effects and outcomes no worse than a comparable control population. This study confirms a potential role for PDT in the management of early breast cancer., Competing Interests: The authors declare no conflict of interest.
- Published
- 2020
- Full Text
- View/download PDF
117. Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis.
- Author
-
Best LM, Leung J, Freeman SC, Sutton AJ, Cooper NJ, Milne EJ, Cowlin M, Payne A, Walshaw D, Thorburn D, Pavlov CS, Davidson BR, Tsochatzis E, Williams NR, and Gurusamy KS
- Subjects
- Bayes Theorem, Humans, Immunosuppression Therapy methods, Network Meta-Analysis, Quality of Life, Randomized Controlled Trials as Topic, Immunosuppressive Agents administration & dosage, Liver Transplantation, Transplantation Immunology
- Abstract
Background: Liver transplantation is considered the definitive treatment for people with liver failure. As part of post-liver transplantation management, immunosuppression (suppressing the host immunity) is given to prevent graft rejections. Immunosuppressive drugs can be classified into those that are used for a short period during the beginning phase of immunosuppression (induction immunosuppression) and those that are used over the entire lifetime of the individual (maintenance immunosuppression), because it is widely believed that graft rejections are more common during the first few months after liver transplantation. Some drugs such as glucocorticosteroids may be used for both induction and maintenance immunosuppression because of their multiple modalities of action. There is considerable uncertainty as to whether induction immunosuppression is necessary and if so, the relative efficacy of different immunosuppressive agents., Objectives: To assess the comparative benefits and harms of different induction immunosuppressive regimens in adults undergoing liver transplantation through a network meta-analysis and to generate rankings of the different induction immunosuppressive regimens according to their safety and efficacy., Search Methods: We searched CENTRAL, MEDLINE, Embase, Science Citation Index Expanded, World Health Organization International Clinical Trials Registry Platform, and trials registers until July 2019 to identify randomised clinical trials in adults undergoing liver transplantation., Selection Criteria: We included only randomised clinical trials (irrespective of language, blinding, or status) in adults undergoing liver transplantation. We excluded randomised clinical trials in which participants had multivisceral transplantation and those who already had graft rejections., Data Collection and Analysis: We performed a network meta-analysis with OpenBUGS using Bayesian methods and calculated the odds ratio (OR), rate ratio, and hazard ratio (HR) with 95% credible intervals (CrIs) based on an available case analysis, according to National Institute of Health and Care Excellence Decision Support Unit guidance., Main Results: We included a total of 25 trials (3271 participants; 8 treatments) in the review. Twenty-three trials (3017 participants) were included in one or more outcomes in the review. The trials that provided the information included people undergoing primary liver transplantation for various indications and excluded those with HIV and those with renal impairment. The follow-up in the trials ranged from three to 76 months, with a median follow-up of 12 months among trials. All except one trial were at high risk of bias, and the overall certainty of evidence was very low. Overall, approximately 7.4% of people who received the standard regimen of glucocorticosteroid induction died and 12.2% developed graft failure. All-cause mortality and graft failure was lower with basiliximab compared with glucocorticosteroid induction: all-cause mortality (HR 0.53, 95% CrI 0.31 to 0.93; network estimate, based on 2 direct comparison trials (131 participants; low-certainty evidence)); and graft failure (HR 0.44, 95% CrI 0.28 to 0.70; direct estimate, based on 1 trial (47 participants; low-certainty evidence)). There was no evidence of differences in all-cause mortality and graft failure between other induction immunosuppressants and glucocorticosteroids in either the direct comparison or the network meta-analysis (very low-certainty evidence). There was also no evidence of differences in serious adverse events (proportion), serious adverse events (number), renal failure, any adverse events (proportion), any adverse events (number), liver retransplantation, graft rejections (any), or graft rejections (requiring treatment) between other induction immunosuppressants and glucocorticosteroids in either the direct comparison or the network meta-analysis (very low-certainty evidence). However, because of the wide CrIs, clinically important differences in these outcomes cannot be ruled out. None of the studies reported health-related quality of life., Funding: the source of funding for 14 trials was drug companies who would benefit from the results of the study; two trials were funded by neutral organisations who have no vested interests in the results of the study; and the source of funding for the remaining nine trials was unclear., Authors' Conclusions: Based on low-certainty evidence, basiliximab induction may decrease mortality and graft failure compared to glucocorticosteroids induction in people undergoing liver transplantation. However, there is considerable uncertainty about this finding because this information is based on small trials at high risk of bias. The evidence is uncertain about the effects of different induction immunosuppressants on other clinical outcomes, including graft rejections. Future randomised clinical trials should be adequately powered, employ blinding, avoid post-randomisation dropouts (or perform intention-to-treat analysis), and use clinically important outcomes such as mortality, graft failure, and health-related quality of life., (Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
118. Deep Brain Stimulation Results in Greater Symptomatic Improvement in Tourette Syndrome than Conservative Measures: A Meta-Analysis.
- Author
-
Mahajan UV, Purger DA, Mantovani A, Williams NR, Espil FM, Han SS, Stein SC, and Halpern CH
- Subjects
- Clinical Trials as Topic methods, Conservative Treatment trends, Deep Brain Stimulation trends, Humans, Treatment Outcome, Conservative Treatment methods, Deep Brain Stimulation methods, Tourette Syndrome diagnostic imaging, Tourette Syndrome therapy
- Abstract
Introduction: Deep brain stimulation (DBS) has emerged as a safe and effective therapy for refractory Tourette syndrome (TS). Recent studies have identified several neural targets as effective in reducing TS symptoms with DBS, but, to our knowledge, none has compared the effectiveness of DBS with conservative therapy., Methods: A literature review was performed to identify studies investigating adult patient outcomes reported as Yale Global Tic Severity Scale (YGTSS) scores after DBS surgery, pharmacotherapy, and psychotherapy. Data were pooled using a random-effects model of inverse variance-weighted meta-analysis (n = 168 for DBS, n = 131 for medications, and n = 154 for behavioral therapy)., Results: DBS resulted in a significantly greater reduction in YGTSS total score (49.9 ± 17.5%) than pharmacotherapy (22.5 ± 15.2%, p = 0.001) or psychotherapy (20.0 ± 11.3%, p < 0.001), with a complication (adverse effect) rate of 0.15/case, 1.13/case, and 0.60/case, respectively., Conclusion: Our data suggest that adult patients with refractory TS undergoing DBS experience greater symptomatic improvement with surprisingly low morbidity than can be obtained with pharmacotherapy or psychotherapy., (© 2020 S. Karger AG, Basel.)
- Published
- 2020
- Full Text
- View/download PDF
119. Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial.
- Author
-
Treasure T, Farewell V, Macbeth F, Monson K, Williams NR, Brew-Graves C, Lees B, Grigg O, and Fallowfield L
- Subjects
- Adult, Aged, Aged, 80 and over, Colorectal Neoplasms surgery, Female, Humans, Male, Middle Aged, Neoplasm Staging, Survival Rate, Watchful Waiting, Colorectal Neoplasms mortality, Colorectal Neoplasms pathology, Lung Neoplasms secondary, Lung Neoplasms surgery, Metastasectomy methods
- Abstract
Background: Lung metastasectomy in the treatment of advanced colorectal cancer has been widely adopted without good evidence of survival or palliative benefit. We aimed to test its effectiveness in a randomised controlled trial (RCT)., Methods: Multidisciplinary teams in 13 hospitals recruited participants with potentially resectable lung metastases to a multicentre, two-arm RCT comparing active monitoring with or without metastasectomy. Other local or systemic treatments were decided by the local team. Randomisation was remote and stratified by site with minimisation for age, sex, primary cancer stage, interval since primary resection, prior liver involvement, the number of metastases, and carcinoembryonic antigen level. The central Trial Management Group were blind to patient allocation until completion of the analysis. Analysis was on intention to treat with a margin for non-inferiority of 10%., Results: Between December 2010 and December 2016, 65 participants were randomised. Characteristics were well-matched in the two arms and similar to those in reported studies: age 35 to 86 years (interquartile range (IQR) 60 to 74); primary resection IQR 16 to 35 months previously; stage at resection T1, 2 or 3 in 3, 8 and 46; N1 or N2 in 31 and 26; unknown in 8. Lung metastases 1 to 5 (median 2); 16/65 had previous liver metastases; carcinoembryonic antigen normal in 55/65. There were no other interventions in the first 6 months, no crossovers from control to treatment, and no treatment-related deaths or major adverse events. The Hazard ratio for death within 5 years, comparing metastasectomy with control, was 0.82 (95%CI 0.43, 1.56)., Conclusions: Because of poor and worsening recruitment, the study was stopped. The small number of participants in the trial (N = 65) precludes a conclusive answer to the research question given the large overlap in the confidence intervals in the proportions still alive at all time points. A widely held belief is that the 5-year absolute survival benefit with metastasectomy is about 35%: 40% after metastasectomy compared to < 5% in controls. The estimated survival in this study was 38% (23-62%) for metastasectomy patients and 29% (16-52%) in the well-matched controls. That is the new and important finding of this RCT., Trial Registration: ClinicalTrials.gov, ID: NCT01106261. Registered on 19 April 2010.
- Published
- 2019
- Full Text
- View/download PDF
120. Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism.
- Author
-
Williams NR, Heifets BD, Bentzley BS, Blasey C, Sudheimer KD, Hawkins J, Lyons DM, and Schatzberg AF
- Subjects
- Adult, Antidepressive Agents therapeutic use, Cross-Over Studies, Depressive Disorder, Treatment-Resistant drug therapy, Double-Blind Method, Excitatory Amino Acid Antagonists therapeutic use, Female, Humans, Ketamine metabolism, Male, Middle Aged, Naltrexone pharmacology, Psychiatric Status Rating Scales, Suicidal Ideation, Suicide psychology, Treatment Outcome, Ketamine therapeutic use, Narcotic Antagonists metabolism, Receptors, Opioid metabolism
- Abstract
We recently reported that naltrexone blocks antidepressant effects of ketamine in humans, indicating that antidepressant effects of ketamine require opioid receptor activation. However, it is unknown if opioid receptors are also involved in ketamine's antisuicidality effects. Here, in a secondary analysis of our recent clinical trial, we test whether naltrexone attenuates antisuicidality effects of ketamine. Participants were pretreated with naltrexone or placebo prior to intravenous ketamine in a double-blinded crossover design. Suicidality was measured with the Hamilton Depression Rating Scale item 3, Montgomery-Åsberg Depression Rating Scale item 10, and Columbia Suicide Severity Rating Scale. In the 12 participants who completed naltrexone and placebo conditions, naltrexone attenuated the antisuicidality effects of ketamine on all three suicidality scales/subscales (linear mixed model, fixed pretreatment effect, p < 0.01). Results indicate that opioid receptor activation plays a significant role in the antisuicidality effects of ketamine.
- Published
- 2019
- Full Text
- View/download PDF
121. Extending the Quantum Coherence of a Near-Surface Qubit by Coherently Driving the Paramagnetic Surface Environment.
- Author
-
Bluvstein D, Zhang Z, McLellan CA, Williams NR, and Jayich ACB
- Abstract
Surfaces enable useful functionalities for quantum systems, e.g., as interfaces to sensing targets, but often result in surface-induced decoherence where unpaired electron spins are common culprits. Here we show that the coherence time of a near-surface qubit is increased by coherent radio-frequency driving of surface electron spins, where we use a diamond nitrogen-vacancy (NV) center as a model qubit. This technique is complementary to other methods of suppressing decoherence and, importantly, requires no additional materials processing or control of the qubit. Further, by combining driving with the increased magnetic susceptibility of the double-quantum basis, we realize an overall fivefold sensitivity enhancement in NV magnetometry. Informed by our results, we discuss a path toward relaxation-limited coherence times for near-surface NV centers. The surface-spin driving technique presented here is broadly applicable to a wide variety of qubit platforms afflicted by surface-induced decoherence.
- Published
- 2019
- Full Text
- View/download PDF
122. Multimodal characterization of the human nucleus accumbens.
- Author
-
Cartmell SC, Tian Q, Thio BJ, Leuze C, Ye L, Williams NR, Yang G, Ben-Dor G, Deisseroth K, Grill WM, McNab JA, and Halpern CH
- Subjects
- Animals, Brain Mapping methods, Cerebral Cortex diagnostic imaging, Diffusion Tensor Imaging, Electric Stimulation, Female, Humans, Image Processing, Computer-Assisted, Male, Mice, Models, Neurological, Neural Pathways anatomy & histology, Neural Pathways diagnostic imaging, Neural Pathways physiology, Nucleus Accumbens diagnostic imaging, Axons physiology, Cerebral Cortex anatomy & histology, Cerebral Cortex physiology, Nucleus Accumbens anatomy & histology, Nucleus Accumbens physiology
- Abstract
Dysregulation of the nucleus accumbens (NAc) is implicated in numerous neuropsychiatric disorders. Treatments targeting this area directly (e.g. deep brain stimulation) demonstrate variable efficacy, perhaps owing to non-specific targeting of a functionally heterogeneous nucleus. Here we provide support for this notion, first observing disparate behavioral effects in response to direct simulation of different locations within the NAc in a human patient. These observations motivate a segmentation of the NAc into subregions, which we produce from a diffusion-tractography based analysis of 245 young, unrelated healthy subjects. We further explore the mechanism of these stimulation-induced behavioral responses by identifying the most probable subset of axons activated using a patient-specific computational model. We validate our diffusion-based segmentation using evidence from several modalities, including MRI-based measures of function and microstructure, human post-mortem immunohistochemical staining, and cross-species comparison of cortical-NAc projections that are known to be conserved. Finally, we visualize the passage of individual axon bundles through one NAc subregion in a post-mortem human sample using CLARITY 3D histology corroborated by 7T tractography. Collectively, these findings extensively characterize human NAc subregions and provide insight into their structural and functional distinctions with implications for stereotactic treatments targeting this region., (Copyright © 2019. Published by Elsevier Inc.)
- Published
- 2019
- Full Text
- View/download PDF
123. Defect segregation facilitates oxygen transport at fluorite UO 2 grain boundaries.
- Author
-
Symington AR, Molinari M, Brincat NA, Williams NR, and Parker SC
- Abstract
An important challenge for modelling transport in materials for energy applications is that in most applications they are polycrystalline, and hence it is critical to understand the properties in the presence of grain boundaries. Moreover, most grain boundaries are not pristine stoichiometric interfaces and hence dopants are likely to play a significant role. In this paper, we describe our recent work on using atomistic molecular dynamics simulations to model the effect of doped grain boundaries on oxygen transport of fluorite structured UO
2 . UO2 , much like other fluorite grain boundaries, are found to be sinks for oxygen vacancy segregation relative to the grain interior, thus facilitating oxygen transport. Fission products further enhance diffusivity via strong interactions between the impurities and oxygen defects. Doping produces a striking structural alteration in the Σ5 class of grain boundaries that enhances oxygen diffusivity even further. This article is part of a discussion meeting issue 'Energy materials for a low carbon future'.- Published
- 2019
- Full Text
- View/download PDF
124. NeuroSAFE robot-assisted laparoscopic prostatectomy versus standard robot-assisted laparoscopic prostatectomy for men with localised prostate cancer (NeuroSAFE PROOF): protocol for a randomised controlled feasibility study.
- Author
-
Dinneen E, Haider A, Allen C, Freeman A, Briggs T, Nathan S, Brew-Graves C, Grierson J, Williams NR, Persad R, Oakley N, Adshead JM, Huland H, Haese A, and Shaw G
- Subjects
- Adult, Feasibility Studies, Frozen Sections, Humans, Male, Margins of Excision, Multicenter Studies as Topic, Patient Reported Outcome Measures, Quality of Life, Randomized Controlled Trials as Topic, Research Design, Single-Blind Method, Laparoscopy, Prostate innervation, Prostatectomy methods, Prostatic Neoplasms surgery, Robotic Surgical Procedures
- Abstract
Introduction: Robot-assisted laparoscopic prostatectomy (RALP) offers potential cure for localised prostate cancer but is associated with considerable toxicity. Potency and urinary continence are improved when the neurovascular bundles (NVBs) are spared during a nerve spare (NS) RALP. There is reluctance, however, to perform NS RALP when there are concerns that the cancer extends beyond the capsule of the prostate into the NVB, as NS RALP in this instance increases the risk of a positive surgical margin (PSM). The NeuroSAFE technique involves intraoperative fresh-frozen section analysis of the posterolateral aspect of the prostate margin to assess whether cancer extends beyond the capsule. There is evidence from large observational studies that functional outcomes can be improved and PSM rates reduced when the NeuroSAFE technique is used during RALP. To date, however, there has been no randomised controlled trial (RCT) to substantiate this finding. The NeuroSAFE PROOF feasibility study is designed to assess whether it is feasible to randomise men to NeuroSAFE RALP versus a control arm of 'standard of practice' RALP., Methods: NeuroSAFE PROOF feasibility study will be a multicentre, single-blinded RCT with patients randomised 1:1 to either NeuroSAFE RALP (intervention) or standard RALP (control). Treatment allocation will occur after trial entry and consent. The primary outcome will be assessed as the successful accrual of 50 men at three sites over 15 months. Secondary outcomes will be used to aid subsequent power calculations for the definitive full-scale RCT and will include rates of NS; PSM; biochemical recurrence; adjuvant treatments; and patient-reported functional outcomes on potency, continence and quality of life., Ethics and Dissemination: NeuroSAFE PROOF has ethical approval (Regional Ethics Committee reference 17/LO/1978). NeuroSAFE PROOF is supported by National Institute for Healthcare Research Research for Patient Benefit funding (NIHR reference PB-PG-1216-20013). Findings will be made available through peer-reviewed publications., Trial Registration Number: NCT03317990., Competing Interests: Competing interests: Within NeuroSAFE PROOF, laparoscopic ports are supplied by Applied Medical but Applied Medical has had no role in the design, analysis or collection of the data; in writing of the manuscript; or in the decision to submit the manuscript for publication., (© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
125. Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect.
- Author
-
Heifets BD, Williams NR, Bentzley BS, and Schatzberg AF
- Subjects
- Antidepressive Agents, Depression, Humans, Naltrexone, Receptors, Opioid, Alcoholism, Ketamine
- Published
- 2019
- Full Text
- View/download PDF
126. Case Studies in Neuroscience: The electrophysiology of a human obsession in nucleus accumbens.
- Author
-
Miller KJ, Prieto T, Williams NR, and Halpern CH
- Subjects
- Deep Brain Stimulation, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder surgery, Brain Waves physiology, Electrophysiological Phenomena physiology, Nucleus Accumbens physiopathology, Obsessive-Compulsive Disorder physiopathology
- Abstract
Microelectrode recordings were performed during awake deep brain stimulation surgery for obsessive-compulsive disorder, revealing robust brain oscillations that were plainly visible throughout the ventral striatum. There was an elegant topological correspondence between each oscillation and the underlying brain anatomy, most prominently a ~35-Hz gamma-oscillation specific to the nucleus accumbens. Direct provocation of the patient's contamination obsession modulated both firing rate and gamma-oscillation amplitude within the nucleus accumbens. NEW & NOTEWORTHY Surgical implantation of deep brain stimulating electrodes (DBS) to treat obsessive-compulsive disorder (OCD) is an option for patients who have not fully responded to medical intervention or cognitive behavioral therapy. We measured the electrophysiology of a collection of deep brain structures during awake DBS surgery for an OCD patient with an obsession about cleanliness and contamination. The anatomic delineation of these deep brain structures was revealed by distinct brain rhythms, most notably a ~35 Hz oscillation specific to the nucleus accumbens. In the first ever measurement of a human obsessive thought, we found that this ~35-Hz biomarker, as well as the local neuronal action potential rate, were modulated by handing the patient a toothbrush to bring to his face and instructing him to "imagine brushing your teeth with this dirty toothbrush."
- Published
- 2019
- Full Text
- View/download PDF
127. Rigorous Translational Models Are Key to Studying Ketamine's Antidepressant Mechanism: Response to Wang and Kaplin.
- Author
-
Heifets BD, Williams NR, Blasey C, Sudheimer K, Rodriguez CI, and Schatzberg AF
- Subjects
- Antidepressive Agents, Depression, Narcotic Antagonists, Receptors, Opioid, Ketamine
- Published
- 2019
- Full Text
- View/download PDF
128. Robust clinical benefit of multi-target deep brain stimulation for treatment of Gilles de la Tourette syndrome and its comorbidities.
- Author
-
Kakusa B, Saluja S, Tate WJ, Espil FM, Halpern CH, and Williams NR
- Published
- 2019
- Full Text
- View/download PDF
129. The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification.
- Author
-
Hamid S, Donaldson IA, Hu Y, Rodell R, Villarini B, Bonmati E, Tranter P, Punwani S, Sidhu HS, Willis S, van der Meulen J, Hawkes D, McCartan N, Potyka I, Williams NR, Brew-Graves C, Freeman A, Moore CM, Barratt D, Emberton M, and Ahmed HU
- Subjects
- Aged, False Negative Reactions, Humans, Male, Middle Aged, Neoplasm Grading, Prospective Studies, Risk Assessment, Single-Blind Method, Image-Guided Biopsy methods, Magnetic Resonance Imaging, Multimodal Imaging, Prostatic Neoplasms pathology, Ultrasonography
- Abstract
Background: Multiparametric magnetic resonance imaging (mpMRI)-targeted prostate biopsies can improve detection of clinically significant prostate cancer and decrease the overdetection of insignificant cancers. It is unknown whether visual-registration targeting is sufficient or augmentation with image-fusion software is needed., Objective: To assess concordance between the two methods., Design, Setting, and Participants: We conducted a blinded, within-person randomised, paired validating clinical trial. From 2014 to 2016, 141 men who had undergone a prior (positive or negative) transrectal ultrasound biopsy and had a discrete lesion on mpMRI (score 3-5) requiring targeted transperineal biopsy were enrolled at a UK academic hospital; 129 underwent both biopsy strategies and completed the study., Intervention: The order of performing biopsies using visual registration and a computer-assisted MRI/ultrasound image-fusion system (SmartTarget) on each patient was randomised. The equipment was reset between biopsy strategies to mitigate incorporation bias., Outcome Measurements and Statistical Analysis: The proportion of clinically significant prostate cancer (primary outcome: Gleason pattern ≥3+4=7, maximum cancer core length ≥4mm; secondary outcome: Gleason pattern ≥4+3=7, maximum cancer core length ≥6mm) detected by each method was compared using McNemar's test of paired proportions., Results and Limitations: The two strategies combined detected 93 clinically significant prostate cancers (72% of the cohort). Each strategy detected 80/93 (86%) of these cancers; each strategy identified 13 cases missed by the other. Three patients experienced adverse events related to biopsy (urinary retention, urinary tract infection, nausea, and vomiting). No difference in urinary symptoms, erectile function, or quality of life between baseline and follow-up (median 10.5 wk) was observed. The key limitations were lack of parallel-group randomisation and a limit on the number of targeted cores., Conclusions: Visual-registration and image-fusion targeting strategies combined had the highest detection rate for clinically significant cancers. Targeted prostate biopsy should be performed using both strategies together., Patient Summary: We compared two prostate cancer biopsy strategies: visual registration and image fusion. A combination of the two strategies found the most clinically important cancers and should be used together whenever targeted biopsy is being performed., (Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
130. Acceptability and feasibility study of patient-specific 'tumouroids' as personalised treatment screening tools: Protocol for prospective tissue and data collection of participants with confirmed or suspected renal cell carcinoma.
- Author
-
Tran MGB, Neves JB, Stamati K, Redondo P, Cope A, Brew-Graves C, Williams NR, Grierson J, Cheema U, Loizidou M, and Emberton M
- Abstract
Introduction: 'Personalised medicine' aims to tailor interventions to the individual, and has become one of the fastest growing areas of cancer research. One of these approaches is to harvest cancer cells from patients and grow them in the laboratory, which can then be subjected to treatments and the response assessed. We have developed a 3D tumour model with a complex protein matrix that mimics the tumour stroma, cell to cell and cell-matrix interactions seen in vivo , called a tumouroid. In this study, we test the acceptability and feasibility of using this model to establish patient-derived tumouroids., Methods and Analysis: This is a first in-human study using prospective tissue and data collection of adult participants with confirmed or suspected renal cell carcinoma. The goals of the study are to assess patient acceptability to the use of patient-derived tumour models for future treatment decisions, and to assess the feasibility of generating patient-specific renal cancer tumouroids that can be challenged with drugs. These goals will be realised through the collection of tumour samples (expected n = 10), participant-completed questionnaires (expected n = 10), and in-depth semi-structured interviews with patients (expected n = 5). Collected multiregional tumour samples will be dissociated to isolate primary cells which are then expanded in vitro and incorporated into tumouroids. Drug challenge will ensue and the response will be categorised into "responder", "weak responder", and "non-responder". Statistical analysis will be descriptive., Ethics and Dissemination: The study has ethical approval (REC reference 17/LO/1744). Findings will be made available to patients, clinicians, funders, and the National Health Service (NHS) through presentations at national and international meetings, peer-reviewed publications, social media and patient support groups., Trial Registration: Registered on ClinicalTrials.gov (NCT03300102)., (© 2019 The Authors.)
- Published
- 2019
- Full Text
- View/download PDF
131. Nonrigid reconstruction of 3D breast surfaces with a low-cost RGBD camera for surgical planning and aesthetic evaluation.
- Author
-
Lacher RM, Vasconcelos F, Williams NR, Rindermann G, Hipwell J, Hawkes D, and Stoyanov D
- Subjects
- Anatomic Landmarks, Calibration, Esthetics, Female, Humans, Breast anatomy & histology, Breast Neoplasms surgery, Image Processing, Computer-Assisted methods, Imaging, Three-Dimensional methods, Surgery, Computer-Assisted methods, Video Recording instrumentation
- Abstract
Accounting for 26% of all new cancer cases worldwide, breast cancer remains the most common form of cancer in women. Although early breast cancer has a favourable long-term prognosis, roughly a third of patients suffer from a suboptimal aesthetic outcome despite breast conserving cancer treatment. Clinical-quality 3D modelling of the breast surface therefore assumes an increasingly important role in advancing treatment planning, prediction and evaluation of breast cosmesis. Yet, existing 3D torso scanners are expensive and either infrastructure-heavy or subject to motion artefacts. In this paper we employ a single consumer-grade RGBD camera with an ICP-based registration approach to jointly align all points from a sequence of depth images non-rigidly. Subtle body deformation due to postural sway and respiration is successfully mitigated leading to a higher geometric accuracy through regularised locally affine transformations. We present results from 6 clinical cases where our method compares well with the gold standard and outperforms a previous approach. We show that our method produces better reconstructions qualitatively by visual assessment and quantitatively by consistently obtaining lower landmark error scores and yielding more accurate breast volume estimates., (Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
132. Comparative effectiveness of neuroablation and deep brain stimulation for treatment-resistant obsessive-compulsive disorder: a meta-analytic study.
- Author
-
Kumar KK, Appelboom G, Lamsam L, Caplan AL, Williams NR, Bhati MT, Stein SC, and Halpern CH
- Subjects
- Humans, Radiofrequency Ablation, Radiosurgery, Treatment Outcome, Ablation Techniques methods, Deep Brain Stimulation methods, Neurosurgical Procedures methods, Obsessive-Compulsive Disorder therapy
- Abstract
Background: The safety and efficacy of neuroablation (ABL) and deep brain stimulation (DBS) for treatment refractory obsessive-compulsive disorder (OCD) has not been examined. This study sought to generate a definitive comparative effectiveness model of these therapies., Methods: A EMBASE/PubMed search of English-language, peer-reviewed articles reporting ABL and DBS for OCD was performed in January 2018. Change in quality of life (QOL) was quantified based on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and the impact of complications on QOL was assessed. Mean response of Y-BOCS was determined using random-effects, inverse-variance weighted meta-analysis of observational data., Findings: Across 56 studies, totalling 681 cases (367 ABL; 314 DBS), ABL exhibited greater overall utility than DBS. Pooled ability to reduce Y-BOCS scores was 50.4% (±22.7%) for ABL and was 40.9% (±13.7%) for DBS. Meta-regression revealed no significant change in per cent improvement in Y-BOCS scores over the length of follow-up for either ABL or DBS. Adverse events occurred in 43.6% (±4.2%) of ABL cases and 64.6% (±4.1%) of DBS cases (p<0.001). Complications reduced ABL utility by 72.6% (±4.0%) and DBS utility by 71.7% (±4.3%). ABL utility (0.189±0.03) was superior to DBS (0.167±0.04) (p<0.001)., Interpretation: Overall, ABL utility was greater than DBS, with ABL showing a greater per cent improvement in Y-BOCS than DBS. These findings help guide success thresholds in future clinical trials for treatment refractory OCD., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
133. Impact of Hydrogen on the Intermediate Oxygen Clusters and Diffusion in Fluorite Structured UO 2+ x .
- Author
-
Flitcroft JM, Symington AR, Molinari M, Brincat NA, Williams NR, and Parker SC
- Abstract
Uranium dioxide is the most prevalent nuclear fuel. Defect clusters are known to be present in significant concentrations in hyperstoichoimetric uranium oxide, UO
2+ x , and have a significant impact on the corrosion of the material. A detailed understanding of the defect clusters that form is required for accurate diffusion models in UO2+ x . Using ab initio calculations, we show that at low excess oxygen concentration, where defects are mostly isolated oxygen interstitials, hydrogen stabilizes the initial clustering. The simplest cluster at this low excess oxygen stoichiometry consists of a pair of oxygen ions bound to an oxygen vacancy, namely the split mono-interstital, which resembles larger split interstitials clusters in UO2+ x . Our data shows that, depending on local hydrogen concertation, the presence of hydrogen stabilizes this cluster over isolated oxygen interstitials.- Published
- 2019
- Full Text
- View/download PDF
134. Target Population, Dose, and Timing Considerations for Understanding Naltrexone's Subjective Effect: Response to Amiaz.
- Author
-
Heifets BD, Williams NR, Blasey C, Sudheimer K, Rodriguez CI, and Schatzberg AF
- Subjects
- Alcohol Drinking, Antidepressive Agents, Humans, Naltrexone, Narcotic Antagonists, Population, Receptors, Opioid, Alcoholism, Ketamine
- Published
- 2019
- Full Text
- View/download PDF
135. Interpreting Ketamine's Opioid Receptor Dependent Effect: Response to Sanacora.
- Author
-
Heifets BD, Williams NR, Blasey C, Sudheimer K, Rodriguez CI, and Schatzberg AF
- Subjects
- Antidepressive Agents, Depression, Narcotic Antagonists, Receptors, Opioid, Ketamine
- Published
- 2019
- Full Text
- View/download PDF
136. Radiation-induced fibrosis in breast cancer: A protocol for an observational cross-sectional pilot study for personalised risk estimation and objective assessment.
- Author
-
Williams NR, Williams S, Kanapathy M, Naderi N, Vavourakis V, and Mosahebi A
- Abstract
Introduction: About 30% of patients request breast reconstruction following surgery for breast cancer, but radiation therapy negatively influences the outcome. Post-reconstruction radiotherapy is associated with more complications, including more severe capsular contracture and inferior cosmetic results. In general, less fibrosis is seen if autologous reconstruction is performed after radiotherapy, so surgeons will often delay reconstruction until after radiotherapy is complete. Drawbacks to this approach include additional surgery, recuperation, cost, and an extended reconstructive process. Randomised clinical trials are required to determine the best approach., Methods and Analysis: The aim of this cross-sectional pilot study is to see if it is feasible to recruit women, and gather the required data. This information will be used to design a subsequent, larger study whose aim is to identify factors that increase the risk of radiation-induced fibrosis, and use these to develop a personalised risk-prediction tool, to enable the clinician and patient to have a more informed discussion when treatment for breast cancer is being discussed. Identification of the risk factors will also enable the development of methods to minimise the risk, which would have applications in other medical conditions where fibrosis is a problem. In addition, the project will develop objective methods of assessing fibrosis, and will determine the psychological and economic impacts that fibrosis has affected individuals. A better understanding of the long-term effects of radiotherapy on normal tissues such as the heart and lungs may also have applications in other medical conditions where fibrosis is a problem., Ethics and Dissemination: The study has been submitted for ethical approval (REC reference). Findings will be made available to patients and clinicians through presentations at national and international meetings, peer-reviewed publications, social media and patient support groups., Trial Registration: Registered on ClinicalTrials.gov (after REC approval)., (Crown Copyright © 2019 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
137. A medical device registry is long overdue.
- Author
-
Williams NR
- Abstract
Competing Interests: Competing interests: I work in an academic clinical trials unit, specialising in surgical and other non-drug interventional studies.
- Published
- 2019
- Full Text
- View/download PDF
138. Protocol for a feasibility randomised controlled trial of targeted oxygen therapy in mechanically ventilated critically ill patients.
- Author
-
Martin DS, Brew-Graves C, McCartan N, Jell G, Potyka I, Stevens J, Williams NR, McNeil M, O'Driscoll BR, Mythen M, and Grocott MPW
- Subjects
- Biomarkers blood, Critical Care methods, Feasibility Studies, Humans, Hypoxia etiology, Multicenter Studies as Topic, Oxygen Inhalation Therapy adverse effects, Randomized Controlled Trials as Topic, Reactive Oxygen Species blood, Respiratory Insufficiency therapy, United Kingdom, Critical Illness therapy, Oxidative Stress, Oxygen blood, Oxygen Inhalation Therapy methods, Respiration, Artificial
- Abstract
Introduction: Oxygen is the most commonly administered drug to mechanically ventilated critically ill adults, yet little is known about the optimum oxygen saturation (SpO
2 ) target for these patients; the current standard of care is an SpO2 of 96% or above. Small pilot studies have demonstrated that permissive hypoxaemia (aiming for a lower SpO2 than normal by using a lower fractional inspired oxygen concentration (FIO2 )) can be achieved in the critically ill and appears to be safe. This approach has not been evaluated in a National Health Service setting. It is possible that permissive hypoxaemia may be beneficial to critically ill patients thus it requires robust evaluation., Methods and Analysis: Targeted OXygen therapY in Critical illness (TOXYC) is a feasibility randomised controlled trial (RCT) to evaluate whether recruiting patients to a study of permissive hypoxaemia is possible in the UK. It will also investigate biological mechanisms that may underlie the links between oxygenation and patient outcomes. Mechanically ventilated patients with respiratory failure will be recruited from critical care units at two sites and randomised (1:1 ratio) to an SpO2 target of either 88%-92% or ≥96% while intubated with an endotracheal tube. Clinical teams can adjust FIO2 and ventilator settings as they wish to achieve these targets. Clinical information will be collected before, during and after the intervention and blood samples taken to measure markers of systemic oxidative stress. The primary outcome of this study is feasibility, which will be assessed by recruitment rate, protocol adherence and withdrawal rates. Secondary outcomes will include a comparison of standard critical care outcome measures between the two intervention groups, and the measurement of biomarkers of systemic oxidative stress. The results will be used to calculate a sample size, likely number of sites and overall length of time required for a subsequent large multicentre RCT., Ethics and Dissemination: This study was approved by the London - Harrow Research Ethics Committee on 2 November 2017 (REC Reference 17/LO/1334) and received HRA approval on 13 November 2017. Results from this study will be disseminated in peer-reviewed journals, at medical and scientific meetings, in the NIHR Journals Library and patient information websites., Trial Registration Number: NCT03287466; Pre-results., Competing Interests: Competing interests: DSM, MM and MPWG are directors of a company developing an oxygen delivery device (Oxygen Control Ltd). DSM has received honoraria and consultancy fees from Siemens Healthcare, Masimo, Deltex and Edwards Lifesciences. MPWG is the National Specialty Lead for Anaesthesia, Perioperative Medicine and Pain within the UK National Institute of Heath Research Clinical Research Network, an elected council member of the Royal College of Anaesthetists and serves on the board of the Evidence Based Perioperative Medicine (EBPOM) social enterprise and the medical advisory board of Sphere Medical Ltd. MPWG has received honoraria for speaking and/or travel expenses from Edwards Lifesciences, Fresenius-Kabi, BOC Medical (Linde Group), Ely-Lilly Critical Care, and Cortex GmBH. MPWG is executive chair of the Xtreme-Everest Oxygen Research Consortium and joint Editor-in-Chief of the journal Perioperative Medicine. MM is a consultant for Baxter, Edwards Lifesciences and Deltex; his University Chair is supported by Smiths Medical; Elected Council Member Royal College of Anaesthetsists; Editorial Board BJA and Critical Care; Founding Editor-in-Chief Perioperative Medicine., (© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.)- Published
- 2019
- Full Text
- View/download PDF
139. Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.
- Author
-
Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H, Hawkins J, Birnbaum J, Lyons DM, Rodriguez CI, and Schatzberg AF
- Subjects
- Adult, Antidepressive Agents administration & dosage, Cross-Over Studies, Double-Blind Method, Drug Administration Schedule, Female, Humans, Ketamine administration & dosage, Male, Naltrexone administration & dosage, Narcotic Antagonists administration & dosage, Psychiatric Status Rating Scales, Antidepressive Agents therapeutic use, Depressive Disorder, Treatment-Resistant drug therapy, Ketamine therapeutic use, Naltrexone therapeutic use, Narcotic Antagonists therapeutic use
- Abstract
Objective: In addition to N-methyl-d-aspartate receptor antagonism, ketamine produces opioid system activation. The objective of this study was to determine whether opioid receptor antagonism prior to administration of intravenous ketamine attenuates its acute antidepressant or dissociative effects., Method: In a proposed double-blind crossover study of 30 adults with treatment-resistant depression, the authors performed a planned interim analysis after studying 14 participants, 12 of whom completed both conditions in randomized order: placebo or 50 mg of naltrexone preceding intravenous infusion of 0.5 mg/kg of ketamine. Response was defined as a reduction ≥50% in score on the 17-item Hamilton Depression Rating Scale (HAM-D) score on postinfusion day 1., Results: In the interim analysis, seven of 12 adults with treatment-resistant depression met the response criterion during the ketamine plus placebo condition. Reductions in 6-item and 17-item HAM-D scores among participants in the ketamine plus naltrexone condition were significantly lower than those of participants in the ketamine plus placebo condition on postinfusion days 1 and 3. Secondary analysis of all participants who completed the placebo and naltrexone conditions, regardless of the robustness of response to ketamine, showed similar results. There were no differences in ketamine-induced dissociation between conditions. Because naltrexone dramatically blocked the antidepressant but not the dissociative effects of ketamine, the trial was halted at the interim analysis., Conclusions: The findings suggest that ketamine's acute antidepressant effect requires opioid system activation. The dissociative effects of ketamine are not mediated by the opioid system, and they do not appear sufficient without the opioid effect to produce the acute antidepressant effects of ketamine in adults with treatment-resistant depression.
- Published
- 2018
- Full Text
- View/download PDF
140. Recommendations for clinical translation of nanoparticle-enhanced radiotherapy.
- Author
-
Ricketts K, Ahmad R, Beaton L, Cousins B, Critchley K, Davies M, Evans S, Fenuyi I, Gavriilidis A, Harmer QJ, Jayne D, Jefford M, Loizidou M, Macrobert A, Moorcroft S, Naasani I, Ong ZY, Prise KM, Rannard S, Richards T, Schettino G, Sharma RA, Tillement O, Wakefield G, Williams NR, Yaghini E, and Royle G
- Subjects
- Humans, Nanoparticles, Radiotherapy methods
- Abstract
A multi-disciplinary cooperative for nanoparticle-enhanced radiotherapy (NERT) has been formed to review the current status of the field and identify key stages towards translation. Supported by the Colorectal Cancer Healthcare Technologies Cooperative, the cooperative comprises a diverse cohort of key contributors along the translation pathway including academics of physics, cancer and radio-biology, chemistry, nanotechnology and clinical trials, clinicians, manufacturers, industry, standards laboratories, policy makers and patients. Our aim was to leverage our combined expertise to devise solutions towards a roadmap for translation and commercialisation of NERT, in order to focus research in the direction of clinical implementation, and streamline the critical pathway from basic science to the clinic. A recent meeting of the group identified barriers to and strategies for accelerated clinical translation. This commentary reports the cooperative's recommendations. Particular emphasis was given to more standardised and cohesive research methods, models and outputs, and reprioritised research drivers including patient quality of life following treatment. Nanoparticle design criteria were outlined to incorporate scalability of manufacture, understanding and optimisation of biological mechanisms of enhancement and in vivo fate of nanoparticles, as well as existing design criteria for physical and chemical enhancement. In addition, the group aims to establish a long-term and widespread international community to disseminate key findings and create a much-needed cohesive body of evidence necessary for commercial and clinical translation.
- Published
- 2018
- Full Text
- View/download PDF
141. The value of 3D images in the aesthetic evaluation of breast cancer conservative treatment. Results from a prospective multicentric clinical trial.
- Author
-
Cardoso MJ, Vrieling C, Cardoso JS, Oliveira HP, Williams NR, and Dixon JM
- Subjects
- Breast Neoplasms radiotherapy, Esthetics, Female, Humans, Mastectomy, Segmental adverse effects, Photography methods, Prospective Studies, Software, Treatment Outcome, Breast Neoplasms surgery, Imaging, Three-Dimensional methods, Mastectomy, Segmental methods
- Abstract
Purpose: BCCT.core (Breast Cancer Conservative Treatment. cosmetic results) is a software created for the objective evaluation of aesthetic result of breast cancer conservative treatment using a single patient frontal photography. The lack of volume information has been one criticism, as the use of 3D information might improve accuracy in aesthetic evaluation. In this study, we have evaluated the added value of 3D information to two methods of aesthetic evaluation: a panel of experts; and an augmented version of the computational model - BCCT.core3d., Material and Methods: Within the scope of EU Seventh Framework Programme Project PICTURE, 2D and 3D images from 106 patients from three clinical centres were evaluated by a panel of 17 experts and the BCCT.core. Agreement between all methods was calculated using the kappa (K) and weighted kappa (wK) statistics., Results: Subjective agreement between 2D and 3D individual evaluation was fair to moderate. The agreement between the expert classification and the BCCT.core software with both 2D and 3D features was also fair to moderate., Conclusions: The inclusion of 3D images did not add significant information to the aesthetic evaluation either by the panel or the software. Evaluation of aesthetic outcome can be performed using of the BCCT.core software, with a single frontal image., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
142. Multidomain Quantitative Recovery Following Radical Cystectomy for Patients Within the Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Versus Open Radical Cystectomy Randomised Controlled Trial: The First 30 Patients.
- Author
-
Catto JWF, Khetrapal P, Ambler G, Sarpong R, Potyka I, Khan MS, Tan M, Feber A, Bourke L, Noon AP, Dixon S, Goodwin L, Williams NR, Rowe E, Kouparis A, McGrath J, Brew-Graves C, and Kelly JD
- Subjects
- Aged, Female, Humans, Male, Middle Aged, United Kingdom, Cystectomy adverse effects, Cystectomy methods, Outcome Assessment, Health Care methods, Outcome Assessment, Health Care statistics & numerical data, Robotic Surgical Procedures adverse effects, Robotic Surgical Procedures methods, Urinary Bladder Neoplasms surgery, Urinary Diversion adverse effects, Urinary Diversion methods
- Published
- 2018
- Full Text
- View/download PDF
143. Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study.
- Author
-
Catto JWF, Khetrapal P, Ambler G, Sarpong R, Khan MS, Tan M, Feber A, Dixon S, Goodwin L, Williams NR, McGrath J, Rowe E, Koupparis A, Brew-Graves C, and Kelly JD
- Subjects
- Adult, Clinical Protocols, Feasibility Studies, Female, Humans, Male, Urinary Bladder Neoplasms surgery, Cystectomy methods, Robotic Surgical Procedures methods
- Abstract
Introduction: Bladder cancer (BC) is a common malignancy and one of the most expensive to manage. Radical cystectomy (RC) with pelvic lymphadenectomy is a gold standard treatment for high-risk BC. Reductions in morbidity and mortality from RC may be achieved through robot-assisted RC (RARC). Prospective comparisons between open RC (ORC) and RARC have been limited by sample size, use of extracorporeal reconstruction and use of outcomes important for ORC. Conversely, while RARC is gaining in popularity, there is little evidence to suggest it is superior to ORC. We are undertaking a prospective randomised controlled trial (RCT) to compare RARC with intracorporeal reconstruction (iRARC) and ORC using multimodal outcomes to explore qualitative and quantitative recovery after surgery. METHODS AND ANALYSIS: iROC is a multicentre prospective RCT in English National Health Service (NHS) cancer centres. We will randomise 320 patients undergoing RC to either iRARC or ORC. Treatment allocation will occur after trial entry and consent. The primary outcome is days alive and out of hospital within the first 90 days from surgery. Secondary outcomes will measure functional recovery (activity trackers, chair-to-stand tests and health related quality of life (HRQOL) questionnaires), morbidity (complications and readmissions), cost-effectiveness (using EuroQol-5 Domain-5 levels (EQ-5D-5L) and unit costs) and surgeon fatigue. Patients will be analysed according to intention to treat. The primary outcome will be transformed and analysed using regression. All statistical assumptions will be investigated. Secondary outcomes will be analysed using appropriate regression methods. An internal feasibility study of the first 30 patients will evaluate recruitment rates, acceptance of randomised treatment choice, compliance outcome collection and to revise our sample size., Ethics and Dissemination: The study has ethical approval (REC reference 16/NE/0418). Findings will be made available to patients, clinicians, funders and the NHS through peer-reviewed publications, social media and patient support groups., Trial Registration Numbers: ISRCTN13680280 and NCT03049410., Competing Interests: Competing interests: Within iROC, robotic consumables are provider without cost from Intuitive Surgical. JMcG has received educational funding from Intuitive Surgical., (© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2018
- Full Text
- View/download PDF
144. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
- Author
-
Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budäus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G, Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, and Moore CM
- Subjects
- Aged, Biopsy adverse effects, Follow-Up Studies, Humans, Intention to Treat Analysis, Male, Middle Aged, Prostate pathology, Prostatic Neoplasms pathology, Quality Control, Quality of Life, Risk Assessment, Surveys and Questionnaires, Ultrasonography, Interventional, Biopsy methods, Magnetic Resonance Imaging, Prostate diagnostic imaging, Prostatic Neoplasms diagnostic imaging
- Abstract
Background: Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men with a raised prostate-specific antigen level who have not undergone biopsy. However, comparative evidence is limited., Methods: In a multicenter, randomized, noninferiority trial, we assigned men with a clinical suspicion of prostate cancer who had not undergone biopsy previously to undergo MRI, with or without targeted biopsy, or standard transrectal ultrasonography-guided biopsy. Men in the MRI-targeted biopsy group underwent a targeted biopsy (without standard biopsy cores) if the MRI was suggestive of prostate cancer; men whose MRI results were not suggestive of prostate cancer were not offered biopsy. Standard biopsy was a 10-to-12-core, transrectal ultrasonography-guided biopsy. The primary outcome was the proportion of men who received a diagnosis of clinically significant cancer. Secondary outcomes included the proportion of men who received a diagnosis of clinically insignificant cancer., Results: A total of 500 men underwent randomization. In the MRI-targeted biopsy group, 71 of 252 men (28%) had MRI results that were not suggestive of prostate cancer, so they did not undergo biopsy. Clinically significant cancer was detected in 95 men (38%) in the MRI-targeted biopsy group, as compared with 64 of 248 (26%) in the standard-biopsy group (adjusted difference, 12 percentage points; 95% confidence interval [CI], 4 to 20; P=0.005). MRI, with or without targeted biopsy, was noninferior to standard biopsy, and the 95% confidence interval indicated the superiority of this strategy over standard biopsy. Fewer men in the MRI-targeted biopsy group than in the standard-biopsy group received a diagnosis of clinically insignificant cancer (adjusted difference, -13 percentage points; 95% CI, -19 to -7; P<0.001)., Conclusions: The use of risk assessment with MRI before biopsy and MRI-targeted biopsy was superior to standard transrectal ultrasonography-guided biopsy in men at clinical risk for prostate cancer who had not undergone biopsy previously. (Funded by the National Institute for Health Research and the European Association of Urology Research Foundation; PRECISION ClinicalTrials.gov number, NCT02380027 .).
- Published
- 2018
- Full Text
- View/download PDF
145. Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial.
- Author
-
Corica T, Nowak AK, Saunders CM, Bulsara MK, Taylor M, Williams NR, Keshtgar M, Joseph DJ, and Vaidya JS
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Intraoperative Period, Middle Aged, Nurses, Patient Satisfaction, Physicians, Software, Breast Neoplasms radiotherapy, Esthetics, Radiotherapy methods, Treatment Outcome
- Abstract
Background: The purpose of this research was to assess agreement between four rating systems of cosmetic outcome measured in a subset of patients with early breast cancer participating in the randomised TARGIT-A trial. TARGIT-A compared risk-adapted single-dose intra-operative radiotherapy (TARGIT-IORT) to whole breast external beam radiotherapy (EBRT)., Methods: Patients, their Radiation Oncologist and Research Nurse completed a subjective cosmetic assessment questionnaire before radiotherapy and annually thereafter for five years. Objective data previously calculated by the validated BCCT.core software which utilizes digital photographs to score symmetry, colour and scar was also used. Agreement was assessed by the Kappa statistic and longitudinal changes were assessed by generalized estimating equations., Results: Overall, an Excellent-Good (EG) cosmetic result was scored more often than a Fair-Poor (FP) result for both treatment groups across all time points, with patients who received TARGIT-IORT scoring EG more often than those who received EBRT however this was statistically significant at Year 5 only. There was modest agreement between the four rating systems with the highest Kappa score being moderate agreement which was between nurse and doctor scores at Year 1 with Kappa = 0.46 (p < 0.001), 95% CI (0.24, 0.68)., Conclusion: Despite similar overall findings between treatment groups and rating systems, the inter-rater agreement was only modest. This suggests that the four rating systems utilized may not necessarily be used interchangeably and it is arguable that for an outcome such as cosmetic appearance, the patient's point of view is the most important., Trial Registration: TARGIT-A ISRCTN34086741 , Registered 21 July 2004, retrospectively registered.
- Published
- 2018
- Full Text
- View/download PDF
146. High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression.
- Author
-
Williams NR, Sudheimer KD, Bentzley BS, Pannu J, Stimpson KH, Duvio D, Cherian K, Hawkins J, Scherrer KH, Vyssoki B, DeSouza D, Raj KS, Keller J, and Schatzberg AF
- Subjects
- Antidepressive Agents, Humans, Theta Rhythm, Transcranial Magnetic Stimulation, Depressive Disorder, Treatment-Resistant
- Published
- 2018
- Full Text
- View/download PDF
147. Closing the loop on impulsivity via nucleus accumbens delta-band activity in mice and man.
- Author
-
Wu H, Miller KJ, Blumenfeld Z, Williams NR, Ravikumar VK, Lee KE, Kakusa B, Sacchet MD, Wintermark M, Christoffel DJ, Rutt BK, Bronte-Stewart H, Knutson B, Malenka RC, and Halpern CH
- Subjects
- Animals, Female, Humans, Male, Mice, Consummatory Behavior physiology, Delta Rhythm physiology, Nucleus Accumbens physiology
- Abstract
Reward hypersensitization is a common feature of neuropsychiatric disorders, manifesting as impulsivity for anticipated incentives. Temporally specific changes in activity within the nucleus accumbens (NAc), which occur during anticipatory periods preceding consummatory behavior, represent a critical opportunity for intervention. However, no available therapy is capable of automatically sensing and therapeutically responding to this vulnerable moment in time when anticipation-related neural signals may be present. To identify translatable biomarkers for an off-the-shelf responsive neurostimulation system, we record local field potentials from the NAc of mice and a human anticipating conventional rewards. We find increased power in 1- to 4-Hz oscillations predominate during reward anticipation, which can effectively trigger neurostimulation that reduces consummatory behavior in mice sensitized to highly palatable food. Similar oscillations are present in human NAc during reward anticipation, highlighting the translational potential of our findings in the development of a treatment for a major unmet need., Competing Interests: Conflict of interest statement: A.G.M., S.A.S., and H.B.-S. were coauthors on a meeting report published in 2015., (Copyright © 2017 the Author(s). Published by PNAS.)
- Published
- 2018
- Full Text
- View/download PDF
148. Optimization of epidural cortical stimulation for treatment-resistant depression.
- Author
-
Williams NR, Bentzley BS, Hopkins T, Pannu J, Sahlem GL, Takacs I, George MS, Nahas Z, and Short EB
- Published
- 2018
- Full Text
- View/download PDF
149. DETECT I & DETECT II: a study protocol for a prospective multicentre observational study to validate the UroMark assay for the detection of bladder cancer from urinary cells.
- Author
-
Tan WS, Feber A, Dong L, Sarpong R, Rezaee S, Rodney S, Khetrapal P, de Winter P, Ocampo F, Jalil R, Williams NR, Brew-Graves C, and Kelly JD
- Subjects
- Female, Humans, Male, Prospective Studies, Biomarkers, Tumor, Clinical Protocols, Liquid Biopsy methods, Urinary Bladder Neoplasms diagnosis
- Abstract
Background: Haematuria is a common finding in general practice which requires visual inspection of the bladder by cystoscopy as well as upper tract imaging. In addition, patients with non-muscle invasive bladder cancer (NMIBC) often require surveillance cystoscopy as often as three monthly depending on disease risk. However, cystoscopy is an invasive procedure which is uncomfortable, requires hospital attendance and is associated with a risk of urinary tract infection. We have developed the UroMark assay, which can detect 150 methylation specific alteration specific to bladder cancer using DNA from urinary sediment cells., Methods: DETECT I and DETECT II are two multi-centre prospective observational studies designed to conduct a robust validation of the UroMark assay. DETECT I will recruit patients having diagnostic investigations for haematuria to determine the negative predictive value of the UroMark to rule out the presence of bladder cancer. DETECT II will recruit patients with new or recurrent bladder cancer to determine the sensitivity of the UroMark in detecting low, intermediate and high grade bladder cancer. NMIBC patients in DETECT II will be followed up with three monthly urine sample collection for 24 months while having surveillance cystoscopy. DETECT II will include a qualitative analysis of semi-structured interviews to explore patients' experience of being diagnosed with bladder cancer and having cystoscopy and a urinary test for bladder cancer surveillance. Results of the UroMark will be compared to cystoscopy findings and histopathological results in patients with bladder cancer., Discussion: A sensitive and specific urinary biomarker will revolutionise the haematuria diagnostic pathway and surveillance strategies for NMIBC patients. None of the six approved US Food and Drug Administration urinary test are recommended as a standalone test. The UroMark assay is based on next generation sequencing technology which interrogates 150 loci and represents a step change compared to other biomarker panels. This enhances the sensitivity of the test and by using a random forest classifier approach, where the UroMark results are derived from a cut off generated from known outcomes of previous samples, addresses many shortcomings of previous assays., Trial Registration: Both trails are registered on clinicaltrials.gov., Detect I: NCT02676180 (18th December 2015)., Detect Ii: NCT02781428 (11th May 2016).
- Published
- 2017
- Full Text
- View/download PDF
150. Intraoperative prediction of the two axillary lymph node macrometastases threshold in patients with breast cancer using a one-step nucleic acid cytokeratin-19 amplification assay.
- Author
-
Fung V, Kohlhardt S, Vergani P, Zardin GJ, and Williams NR
- Abstract
The aim of the present study was to assess the sensitivity, specificity and practicality of using a one-step nucleic acid amplification (OSNA) assay during breast cancer staging surgery to predict and discriminate between at least 2 involved nodes and more than 2 involved nodes and facilitate the decision to provide axillary conservation in the presence of a low total axillary node tumour burden. A total of 700 consecutive patients, not treated with neo-adjuvant chemotherapy, received intraoperative sentinel lymph node (SLN) analysis using OSNA for cT1-T3 cN0 invasive breast cancer. Patients with at least one macrometastasis on whole-node SLN analysis underwent axillary lymph node dissection (ALND). The total tumour load (TTL) of the macrometastatic SLN sample was compared with the non-sentinel lymph node (NSLN) status of the ALND specimen using routine histological assessment. In total, 122/683 patients (17.9%) were found to have an OSNA TTL indicative of macrometastasis. In addition, 45/122 (37%) patients had NSLN metastases on ALND with a total positive lymph node burden exceeding the American College of Surgeons Oncology Group Z0011 trial threshold of two macrometastatic nodes. The TTL negative predictive value was 0.975 [95% confidence interval (CI), 0.962-0.988]. The area under the curve for the receiver operating characteristic curve was 0.86 (95% CI, 0.81-0.91), indicating that SLN TTL was associated with the prediction (and partitioning) of total axillary disease burden. OSNA identifies a TTL threshold value where, in the presence of involved SLNs, ALND may be avoided. This technique offers objective confidence in adopting conservative management of the axilla in patients with SLN macrometastases.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.